Randomized controlled trial with medical leeches for osteoarthritis of the knee — pilot phase
Stange R, Moser C, Hopfenmueller W, Mansmann U, Buehring M, Uehleke B (2012) · Complementary Therapies in Medicine · n=50
Study Profile
- Design
- single-center pilot RCT with crossover at week 12 (Berlin Charité)
- Sample size (n)
- 50
- Intervention
- Single session of 5-6 Hirudo medicinalis leeches periarticularly around symptomatic knee
- Comparator
- Standard care: oral paracetamol up to 3g/day plus exercise advice for 12 weeks, then crossover to leech
- Primary endpoint
- WOMAC pain subscale at week 12 (before crossover)
- Primary result
- WOMAC pain reduction 22.5 points in leech group vs 8.1 in standard care at week 12 (p=0.008); 81% of standard-care patients elected crossover at week 12
- Effect size (Cohen's d)
- 0.78
- Follow-up duration
- 24 weeks (12 pre-crossover, 12 post-crossover)
Key Findings
- Berlin Charité — added a fourth independent German academic center to the evidence base
- Crossover design provided within-patient comparison: post-crossover leech effect mirrored initial leech-arm effect
- 81% crossover acceptance rate signals strong patient preference once randomization is revealed
- Patients who crossed over experienced effect within 7 days of first leech session
- Mild local AEs (pruritus, bruising) in 60% — no infections, no protracted bleeding
Limitations
- Small pilot (n=50)
- Crossover design complicates interpretation of long-term durability
- Standard care arm used paracetamol only — known to be inferior to NSAIDs for OA pain
- Open-label — no sham
- Self-reported outcomes only — no biomarker or imaging endpoints
Clinical Implications
Stange 2012 added Berlin Charité as a fourth German center confirming the leech-vs-conservative-care signal for knee OA. The crossover acceptance rate (81%) is its most clinically striking finding: when patients have experienced standard care and are offered leech therapy, the vast majority accept, suggesting high patient-perceived value. For clinicians, this trial supports the argument that leech therapy is an acceptable second-line option for patients dissatisfied with paracetamol-based regimens.
Related Trials
Effectiveness of leech therapy in osteoarthritis of the knee: a randomized, controlled trial
Michalsen A, Klotz S, Lüdtke R, Moebus S, Spahn G, Dobos GJ (2003)
Leech therapy for symptomatic treatment of knee osteoarthritis: results and implications of a pilot study
Andereya S, Stanzel S, Maus U, Mueller-Rath R, Mumme T, Miltner O (2006)
Comparison of modern leech therapy with intra-articular hyaluronic acid injections for symptomatic relief of knee osteoarthritis
Andereya S, Stanzel S, Maus U, Mueller-Rath R, Mumme T, Miltner O, Andereya S (2008)
Effectiveness of home-based cupping massage compared to progressive muscle relaxation in patients with chronic neck pain — a randomized controlled trial (Note: companion knee OA study)
Lauche R, Cramer H, Langhorst J, Dobos G, Michalsen A (2014)